Medicure Inc. MCUJF
Annual
Quarterly
No annual revenue total was found in MEDICURE INC.'s SEC filings.
Medicure Inc. (MCUJF) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
$0.13
Dividend per share
None
Shares outstanding
10.44M
+0.0% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MCUJF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Manitoba, Canada
- Headquarters
- Winnipeg
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1133519
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2022 Dec 31, 2022 |
|---|---|
| Diluted EPS | $0.13 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Aug 19, 2026 | Aug 18, 2026 |
| 6-K | Current report (foreign issuer) | Aug 19, 2026 | Aug 18, 2026 |
| 6-K | Current report (foreign issuer) | May 21, 2026 | May 21, 2026 |
| 6-K | Current report (foreign issuer) | May 21, 2026 | May 21, 2026 |
| 6-K | Current report (foreign issuer) | May 21, 2026 | May 21, 2026 |
| 6-K | Current report (foreign issuer) | Apr 24, 2026 | Apr 23, 2026 |
All 481 Medicure Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.